Tirzepatide 30mg

PARTNER-TIRZEPATIDE · 30mg · 30mg · 1 vial per kit

Dual GLP-1 / GIP co-agonist studied in obesity + type-2-diabetes research models.

Read the long-form research →

Curated research reference not yet available for this SKU.

Aurex does not provide dosage or use guidance — Federal regulations governing research-chemical distribution prohibit it. Tirzepatide 30mg is distributed strictly for in-vitro laboratory research. Not for human or veterinary use. Not FDA approved. See [[research-use-only]].